|
Building a
Virtually Integrated
Life Sciences Company
Saturday, December 6, 2008
The traditional business model dominating the pharmaceutical industry for over 100 years is rapidly eroding under new drivers for innovation and increasing financial pressures. Big Pharma as an integrated business from basic scientific research all the way through to marketing, manufacturing, and distribution is rapidly changing as more biotechnology innovation is coming straight from the laboratories of universities and independent research institutions. Smaller companies, often startups, are also using technologies developed at non-profit institutions to develop new lead compounds, new manufacturing methodologies, and new drug delivery vehicles, rather than invest in their own in-house early stage research.
Financing, too, can be a serious challenge. The almost total absence of an initial public offering market requires that venture capital firms reserve money for later rounds and require companies in which they do invest to make that money last much longer than before. Accordingly, today's biotech companies need to build a company around their core strengths and forge relationships with other businesses that provide complementary goods and services in order to conserve resources. The result is no longer the Fully Integrated Pharmaceutical Company, but really more of a Virtually Integrated Pharmaceutical Company. Moreover, this model is being used, not just for pharmaceuticals, but for a wide variety of life science products and services, including diagnostics and devices.
The December 6, 2008 session of the Caltech/MIT Enterprise Forum will focus on the new business model for the biotechnology entrepreneur. What is the essential core of a life sciences business? What parts of the business can be delegated to others? How, and when, does the fledgling company develop relationships with other companies with complementary strengths? What are the nature of the relationships between new companies and the large life sciences companies? Which relationships are advantageous and which are potentially dangerous? Even more important, who invests in these virtual companies and what criteria are they using?
Our panel of speakers will include representatives of two different kinds of research institution, a contract manufacturers, a clinical research organization, a pharmaceutical company, and the venture capital community.
Keynoter
William A. Goddard III
Charles and Mary Ferkel Professor of Chemistry,
Materials Science and Applied Physics
Caltech
Founder, GPC-Rx and Co-Founder, Allozyne, Inc.
Confirmed Speakers
Danny Levin, MA, PhD, CChem, FRSC
President
Norac Pharma
Burkhard Jansen, MD
Director, President, CEO & Founder
Novelix
Andrew Norris PhD
Founder
BCN Biosciences
Richard S. Katzman
Vice President, Academic Affairs
Cedars-Sinai Medical Center
Acting CEO
Tarrot
Brian R. Clark, Ph.D.
Director, Office of Technology Licensing
City of Hope
Moderator
Ira Moskatel
Attorney
Arnold & Porter LLP
Sponsor for this Program
Date
Saturday morning, December 6, 2008
Location
Registration and Continental Breakfast: 8:00 a.m. at Baxter Hall, Caltech
Program: 9:00 a.m. to 11:30 a.m. at Baxter Lecture Hall
Networking: 11:30 a.m. - 12:00 p.m. at Baxter Hall, Caltech
Directions/Maps: Directions to the Forum; Caltech's Interactive Map
Cost
$40 on-line registration fee. $50 at-the-door. $10 for students with full-time student ID (must show at door); free to Caltech students. Registrations are taken on-line up to 12:00 p.m., December 5, 2008. There are no refunds for no-shows.
Founding Sponsors
|
FOR INFORMATION
If you wish to have a friend or colleague added to the Enterprise Forum click, here "Add to Mailing List".
You are receiving this email as a member of the Caltech/MIT Enterprise Forum database. To remove your name from future e-mail communications, simply return this email and key in "remove name" on the subject line.
Contact Information:
Stephanie Yanchinski
295 South Hill Avenue
Pasadena, CA 91106
ph: 626-356-9933
fx: 626-356-7515
email: stephanie.yanchinski@caltech.edu
http://www.entforum.caltech.edu | |
